Lesinurad: what the nephrologist should know
نویسندگان
چکیده
منابع مشابه
Lesinurad: what the nephrologist should know
Lesinurad is an oral inhibitor of the monocarboxylic/urate transporter URAT1 encoded by the SLC22A12 gene. Market authorization was granted in February 2016 in Europe and December 2015 in the USA. As a potentially nephrotoxic uricosuric drug acting on the kidney, nephrologists should become familiar with its indications and safety profile. The approved indication is treatment of gout in combina...
متن کاملStaphylococcus aureus infections in hemodialysis: what a nephrologist should know.
Staphylococcus aureus is a formidable pathogen that has the ability to colonize approximately half the dialysis population without any sign of disease but is also capable of causing wound and tissue infections; fulminant septicemia; and chronic, difficult-to-eradicate and often foreign body-related infections. S. aureus is the main cause of infectious morbidity and mortality in hemodialysis pat...
متن کاملWhat every pediatrician should know about liver transplantation
Liver transplantation is the treatment of choice for children with end-stage liver disease. Improvement in outcomes (allograft and patient survival) has led to widespread use of pediatric LT worldwide. This success is due to improvement in patient selection, transplant surgery, anesthesia/postoperative care and immunosuppression management. This review will focus on different aspects of LT whi...
متن کاملDialysis Modalities: What the Non-Nephrologist Needs to Know
Hospital Physician August 2006 11 D ialysis has been used as a life-saving technique for decades but has been universally available as a chronic therapy for only approximately 30 years. In the United States, there are currently more than 300,000 patients undergoing dialysis, and the prevalence of end-stage renal disease (ESRD) is growing yearly.1 Diabetes and hypertension, which are growing to ...
متن کاملWhat Clinicians Should Know
Case presentation: A 36-year-old nonsmoking, normotensive South Asian man presented to the emergency department of a community hospital with retrosternal chest pain of 60 minutes’ duration. His 12-lead ECG demonstrated 10 mm of STsegment elevation in leads V2 through V6, and he received fibrinolytic therapy within 90 minutes of symptom onset. His pain resolved, but his ST segments only partiall...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Kidney Journal
سال: 2017
ISSN: 2048-8505,2048-8513
DOI: 10.1093/ckj/sfx036